S.o slashed.borg, Denmark

Svend Kaasgaard


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • S.o slashed.borg, DK (1999)
  • Søborg, DK (2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Svend Kaasgaard: Innovator in Antibiotic Production

Introduction

Svend Kaasgaard is a notable inventor based in S.o slashed.borg, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of antibiotics. With a total of 3 patents to his name, Kaasgaard's work has had a substantial impact on antibiotic biosynthesis.

Latest Patents

Kaasgaard's latest patents focus on the process of producing β-lactam antibiotics using microorganisms with increased ligase activity. The first patent details a method for the biosynthesis of β-lactam antibiotics, both in vivo and in vitro. This invention also introduces a novel enzyme that catalyzes specific steps in β-lactam biosynthesis. Additionally, it encompasses a DNA construct encoding this novel enzyme, along with a recombinant vector or transformation vehicle that includes the DNA construct, and a cell that contains either the DNA construct or the recombinant vector.

Career Highlights

Throughout his career, Svend Kaasgaard has worked with prominent companies in the biotechnology sector, including Gist-Brocades N.V. and Novo Nordisk A/S. His experience in these organizations has contributed to his expertise in antibiotic production and biotechnological innovations.

Collaborations

Kaasgaard has collaborated with several professionals in his field, including Klaus Nyegaard Kristiansen and Michi Egel-Mitani. These collaborations have further enhanced his research and development efforts in antibiotic biosynthesis.

Conclusion

Svend Kaasgaard is a distinguished inventor whose work in the production of β-lactam antibiotics has advanced the field of biotechnology. His innovative patents and collaborations reflect his commitment to improving antibiotic production processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…